The following variables were taken into consideration: age at diagnosis, initial symptoms, electrolyte values in sweat, acid steatocrit These measurements were taken during follow-ups except for one which was documented at the first instance,, fecal elastase, genetic testing for cystic fibrosis and data from other studies such as hepatobiliary ultrasound, abdominal CT scans, initial diagnoses, pulmonary involvement, pancreatic involvement, hepatobiliary involvement, enzyme replacement therapy, food allergy diagnoses, type of allergy, endoscopy, pathological studies, skin tests and ImmunoCAP testing.
Se tomaron las siguientes variables: edad al diagnóstico, síntomas al comienzo, valores de electrolitos en sudor, esteatocrito ácido la mayoría de los valores procedentes de datos del seguimiento, excepto uno, documentado en la primera vez, elastasa fecal, estudio genético para fibrosis quística, otros estudios como ecografía hepatobiliar, TAC de abdomen, diagnósticos iniciales, compromiso pulmonar, compromiso pancreático y/o compromiso hepatobiliar, terapia de reemplazo enzimático, diagnóstico de alergia alimentaria, tipo de manifestación de alergia alimentaria, estudio endoscópico y de patología, pruebas cutáneas e inmunocaps.